Drug details

Duobrii (halobetasol propionate and tazarotene lotion)

type of Antipsoriatics, Topical

Duobrii (halobetasol propionate and tazarotene) Lotion is a combination of a corticosteroid and a retinoid indicated for the topical treatment of plaque psoriasis in adults.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• nausea,
• diarrhea,
• tiredness,
• blurred vision,
• dry mouth,
• increased thirst,
• increased urination,
• fruity breath odor,
• slow wound healing,
• thinning or discolored skin,
• increased body hair,
• muscle weakness,
• mood changes,
• menstrual changes, and
• sexual changes
• eye pain,
• tunnel vision,
• seeing halos around lights,
• irritation of treated skin,
• sunburn,
• weight gain (especially in your face, upper back and torso),

The following drugs are related to Duobrii, either as a replacement or used together:

• Humira (adalimumab injection solution for subcutaneous administration)
• Cyltezo (adalimumab-adbm injection, for subcutaneous use)
• Imraldi (adalimumab-xxxx injection, for subcutaneous use)
• Otezla (apremilast tablets)
• Siliq (brodalumab injection for subcutaneous use)
• Cimzia (certolizumab pegol injection)
• Cosentyx (secukinumab injection)
• Eucrisa Ointment (crisaborole)
• Sotyktu (deucravacitinib tablets)
• Dupixent (dupilumab injection)
• Elidel (pimecrolimus cream)
• Enbrel (etanercept)
• Simponi Aria (golimumab for infusion)
• Simponi Injection (golimumab injection)
• Remicade (infliximab)
• Taltz (ixekizumab injection, for subcutaneous use)
• Skyrizi (risankizumab-rzaa injection)
• Zoryve (roflumilast cream)
• Stelara Injection (ustekinumab)